TrialStem cells translational medicine2020

Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open-label, controlled phase II clinical trial.

Chih-Chao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.